The Stop TB Partnership's Working Group on New TB Drugs (WGND) has launched an interactive platform that will mobilize robust discussion around the ne...
The Global Alliance for TB Drug Development (TB Alliance) today announced the appointment of Dr. Carlos Morel to its Board of Directors. Dr. Morel is ...
The Global Alliance for TB Drug Development (TB Alliance) today announced the election of Dr. Maarten van Cleeff as President of its Stakeholders Asso...
New York, NY– January 11, 2010 The Global Alliance for TB Drug Development (TB Alliance), a not-for-profit product development partnership accel...
GUANGZHOU, China, Jan 6 (Reuters) - China, saddled with the world's second largest tuberculosis burden after India, is fighting an uphill battle again...
UNITAID is a global health initiative, established to provide sustainable, predictable and additional funding to significantly impact on market dynami...
CANCUN, Mexico (Reuters) - In Uganda, health experts are getting laboratories ready and preparing villagers in two districts for a large clinical tria...
On World AIDS Day, it is important to recognize the tragedy of HIV/AIDS, the millions of lives that it has claimed, economic hardship it has caused, a...
The TB community voice is essential to stopping the epidemic. Here, a health worker, activist, and TB Alliance Community Engagement coordinator talks ...
Findings from an assessment of global clinical trial sites and mycobacteriology labs for their capacity to conduct registration-standard TB drug trial...
Press Contact: press@tballiance.org
Falling Short: Ensuring Access to Simple, Safe and Effective First-Line Medicines for Tuberculosis
New TB Regimens: What Countries Want
Pathway to Patients
Policy on the Compassionate / Emergency Use of Experimental TB Alliance Drugs